GR3006561T3 - - Google Patents

Info

Publication number
GR3006561T3
GR3006561T3 GR920402935T GR920402935T GR3006561T3 GR 3006561 T3 GR3006561 T3 GR 3006561T3 GR 920402935 T GR920402935 T GR 920402935T GR 920402935 T GR920402935 T GR 920402935T GR 3006561 T3 GR3006561 T3 GR 3006561T3
Authority
GR
Greece
Prior art keywords
protein products
products
viruses
inactivate
precipitating
Prior art date
Application number
GR920402935T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006561T3 publication Critical patent/GR3006561T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y10S424/807—Monoclonal
    • Y10S424/808—Human
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y10S530/865—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR920402935T 1988-12-20 1992-12-16 GR3006561T3 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/287,368 US4939176A (en) 1988-12-20 1988-12-20 Viral inactivation process

Publications (1)

Publication Number Publication Date
GR3006561T3 true GR3006561T3 (cg-RX-API-DMAC7.html) 1993-06-30

Family

ID=23102591

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402935T GR3006561T3 (cg-RX-API-DMAC7.html) 1988-12-20 1992-12-16

Country Status (9)

Country Link
US (1) US4939176A (cg-RX-API-DMAC7.html)
EP (1) EP0374625B1 (cg-RX-API-DMAC7.html)
JP (1) JP2601551B2 (cg-RX-API-DMAC7.html)
AT (1) ATE82510T1 (cg-RX-API-DMAC7.html)
AU (1) AU618157B2 (cg-RX-API-DMAC7.html)
CA (1) CA1340211C (cg-RX-API-DMAC7.html)
DE (1) DE68903558T2 (cg-RX-API-DMAC7.html)
ES (1) ES2052872T3 (cg-RX-API-DMAC7.html)
GR (1) GR3006561T3 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001367A1 (en) * 1989-07-20 1991-02-07 Bioeng, Inc. Supercritical fluid disruption of and extraction from microbial cells
WO1991002789A1 (en) * 1989-08-16 1991-03-07 Rorer International (Overseas) Inc. Treatment of immobilized matrices with antimicrobial agents to remove pyrogen-producing organisms and pyrogens
US5202246A (en) * 1989-08-16 1993-04-13 Armour Pharmaceutical Company Treatment of immobilized matrices for preparation of pharmaceutical and biological products with anti-microbial agents to remove pyrogen-producing organisms and pyrogens
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
ES2074490T5 (es) * 1990-03-22 2004-02-16 Biotest Pharma Gmbh Procedimiento para la elaboracion de un preparado de inmunoglobulina g tolerable por via intravenosa.
AT408191B (de) * 1991-08-19 2001-09-25 Haemosan Erzeugung Pharmazeuti Verfahren zur inaktivierung von prionen
US5486293A (en) * 1994-03-21 1996-01-23 Hemasure, Inc. Removal of small exogenous molecules from biological fluids
US5561115A (en) 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
AUPO410696A0 (en) * 1996-12-06 1997-01-09 Csl Limited Inactivation of viruses by incubation with caprylate
AU717541B2 (en) * 1996-12-06 2000-03-30 Csl Limited Inactivation of viruses by incubation with caprylate
US6955917B2 (en) * 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material
WO2003072123A1 (fr) * 2002-02-28 2003-09-04 Nipro Corporation Preparations d'albumine stabilisees
US20040022792A1 (en) * 2002-06-17 2004-02-05 Ralph Klinke Method of stabilizing proteins at low pH
EP1718675B2 (en) 2004-02-27 2017-01-25 Octapharma AG A method of providing a purified, virus safe antibody preparation
CN1314447C (zh) * 2004-04-12 2007-05-09 爱华生物科技(香港)有限公司 一种具有抑制蛋白酶作用的药物的制备方法
US20050272917A1 (en) * 2004-05-14 2005-12-08 Hematech, Llc Methods for immunoglobulin purification
CN101534920B (zh) * 2006-11-01 2013-10-16 比奥根艾迪克Ma公司 通过低ph和二价阳离子分离生物大分子的方法
JP5631301B2 (ja) * 2008-04-16 2014-11-26 バイオジェン・アイデック・エムエイ・インコーポレイテッド ポリアルキレングリコールおよび遷移金属を用いて生体高分子を単離する方法
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
DE102010054767B4 (de) 2010-12-16 2013-02-21 Previpharma Ag Verfahren zur Trennung, Aufkonzentration und/oder Reinigung von (Blut)Plasmaprotein, Viren oder Virenbestandteilen
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
AU2013205138B2 (en) 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
SG11201603028SA (en) 2013-10-18 2016-05-30 Universität Für Bodenkultur Wien Purification of proteins
KR102238133B1 (ko) * 2013-11-15 2021-04-09 제넨테크, 인크. 환경-친화적 세제를 사용한 바이러스 불활성화 방법
ES2975172T1 (es) * 2014-04-30 2024-07-03 Novo Nordisk As Métodos para la purificación de proteínas usando ácido caprílico
WO2016207353A1 (en) 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4534972A (en) * 1983-03-29 1985-08-13 Miles Laboratories, Inc. Protein compositions substantially free from infectious agents
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
US4762714A (en) * 1986-04-08 1988-08-09 Miles Laboratories, Inc. Preparation of retrovirus-free immunoglobulins
FR2630115B1 (fr) * 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue

Also Published As

Publication number Publication date
US4939176A (en) 1990-07-03
ATE82510T1 (de) 1992-12-15
ES2052872T3 (es) 1994-07-16
DE68903558D1 (de) 1992-12-24
AU618157B2 (en) 1991-12-12
DE68903558T2 (de) 1993-04-01
EP0374625A3 (en) 1991-08-07
AU4698789A (en) 1990-06-28
CA1340211C (en) 1998-12-15
EP0374625A2 (en) 1990-06-27
JP2601551B2 (ja) 1997-04-16
JPH02273175A (ja) 1990-11-07
EP0374625B1 (en) 1992-11-19

Similar Documents

Publication Publication Date Title
GR3006561T3 (cg-RX-API-DMAC7.html)
ES8506082A1 (es) Procedimiento para la inactivacion de germenes patogenos, capaces de reproducirse
Franks et al. Cyclic GMP stimulation and inhibition of cyclic AMP phosphodiesterase from thymic lymphocytes
DE3674941D1 (de) Ozonentkeimung von blut und blutprodukten.
EP0727938A4 (en) Device and method for photoactivation
DK0400958T3 (da) Levende vacciner
AU8168187A (en) Pasteurization of immunoglobulin solutions
DE3776367D1 (de) Sterilisationsverfahren.
ES2056108T3 (es) Empleo de interacciones anticuerpo/antigeno para proteger o modular la actividad biologica.
ATE257016T1 (de) Herstellung von virusinaktivierten intravenös injektierbaren globulin aus immunserum
ATE168717T1 (de) Zellkulturverfahren und medium für das wachstum adhärenter tierzellen
EP0200157A3 (en) Use of an aqueous stabilized chlorite matrix solution in infectious conditions
GR930300100T1 (cg-RX-API-DMAC7.html)
NO882242D0 (no) Stabilisering av biologiske og farmasoeytiske produkter under varmeinaktivering av virale- og bakterielle forurensninger.
DE3477401D1 (en) Immobilization of catalytically active microorganisms in agar gel fibers
ES2077707T3 (es) Procedimiento para la inactivacion de la actividad biologica de adn.
FI892769A0 (fi) Foerfarande foer inaktivering av den rekombinanta dna:n.
Vais et al. Amperometric electrode for glucose with immobilized bacteria(Pseudomonas fluorescens).
DE3479744D1 (en) Associations of prokaryotic organisms and eukaryotic plant cells
DE69027441D1 (en) Ribozymenhemmer
FR2638234B1 (fr) Support pour molecules biologiquement actives ou lui-meme biologiquement actif, son procede de preparation et son application en biologie
Akanji et al. Effect of repeated administration of suramin on alkaline phosphatase activity in rat kidney.
Watkins et al. Enhancement of bovine pancreatic ribonuclease activity by mercaptoethanol
Dube et al. Effect of fungicides on pectolytic enzyme production by Verticillium albo-atrum.
JPS6463600A (en) Method for purifying vitronectin